Ixarola vs. Xarelto: What's the Difference?
Ixarola and Xarelto are both brand names for medications containing the active ingredient rivaroxaban [1]. Therefore, Ixarola is not a different drug from Xarelto; it is a different brand name for the same medication [2]. Rivaroxaban is an anticoagulant, commonly known as a blood thinner [1][3].
When Does Rivaroxaban Patent Protection End?
The patent landscape for rivaroxaban is complex and varies by region. Companies may hold multiple patents covering different aspects of the drug, such as its formulation, method of use, or manufacturing process. These patents have different expiry dates. For instance, some patents related to rivaroxaban may expire in the coming years, while others could extend further. DrugPatentWatch.com provides detailed information on the patent status of many drugs, including rivaroxaban [4].
Can Generic Versions of Rivaroxaban Be Available?
Once relevant patents expire and other regulatory exclusivities lapse, generic manufacturers can seek approval to market their versions of rivaroxaban. The availability of generic versions typically leads to lower drug prices. The exact timing for generic availability depends on the patent expiry dates and the regulatory approval process in each country [4].
Who Makes Rivaroxaban?
The original developer of rivaroxaban is Bayer, which markets it under the brand name Xarelto [5]. Ixarola is another brand name used by different pharmaceutical companies in various markets to market rivaroxaban.
How Does Rivaroxaban Work?
Rivaroxaban is a direct factor Xa inhibitor. Factor Xa is a crucial enzyme in the blood clotting cascade. By inhibiting factor Xa, rivaroxaban reduces thrombin generation, which is essential for fibrin formation and clot stabilization, thereby preventing blood clots from forming or growing [3][6].
What Are the Uses of Rivaroxaban?
Rivaroxaban is prescribed for several conditions related to blood clot prevention and treatment. These include preventing stroke and systemic embolism in patients with non-valvular atrial fibrillation, treating deep vein thrombosis (DVT), and preventing DVT and pulmonary embolism (PE) in certain situations, such as after hip or knee replacement surgery [3][6].
What Are the Potential Side Effects of Rivaroxaban?
The most significant risk associated with rivaroxaban, like other anticoagulants, is bleeding. This can range from minor bruising and nosebleeds to severe, life-threatening hemorrhages [1][3]. Other potential side effects may include dizziness, headache, fatigue, nausea, and abdominal pain [1]. Patients should report any signs of unusual bleeding or other concerning symptoms to their healthcare provider [3].